In rheumatoid arthritis (RA), the use of disease modifying drugs and biologics has transformed the treatment and outcomes of patients over the past 20 years, with methotrexate (MTX) often regarded as the gold standard treatment. However, in spite of its efficacy and safety, average adherence rates to oral MTX are relatively poor, at just 66% (Scheiman-Elazary et al, 2016). General practice nurses (GPNs) and the wider multidisciplinary team have a vital role to play, not only in advising patients about their RA

treatment, but also entering into a collaborative dialogue about what treatment and format may suit them best.